Angiotensin receptor-neprilysin inhibitor treatment in people with chronic obstructive pulmonary disease and heart failure
In people with both COPD and HF, ARNI treatment is associated with fewer respiratory complications compared to RASi.
Authors
- Tinghui Liu (ORCID: https://orcid.org/0009-0001-9634-3715)
- Wei Hsu (ORCID: https://orcid.org/0000-0001-6738-6030)
- Po‐Yu Huang (ORCID: https://orcid.org/0000-0002-8682-1322)
- Chih‐Cheng Lai (ORCID: https://orcid.org/0000-0002-6334-2388)
- Wan‐Hsuan Hsu (ORCID: https://orcid.org/0000-0002-2517-1792)
- Ya‐Wen Tsai (ORCID: https://orcid.org/0000-0003-4630-3923)
- Jheng‐Yan Wu (ORCID: https://orcid.org/0000-0002-3290-1909)
- Khai-Chi Hu
- Kuang‐Ming Liao (ORCID: https://orcid.org/0000-0003-4364-8248)
- Min‐Hsiang Chuang (ORCID: https://orcid.org/0000-0002-8538-4861)
- Bo-Wen Shiau
Institutions
- National Sun Yat-sen University (TW)
- Min-Hwei College of Health Care Management (TW)
- Chi Mei Medical Center (TW)
- National Cheng Kung University (TW)
Publication Details
- Journal
- Communications Medicine
- Published
- 2025-10-16
- DOI
- https://doi.org/10.1038/s43856-025-01140-x
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00